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Physical activity appears to be inversely related to risk of breast cancer, yet the results remain inconsistent. To evaluate this relation
among premenopausal women and examine variation in risk according to level of obesity and use of oral contraceptives (OCs), the
authors examined data from the Nurses’ Health Study II. During 10 years of follow-up, 849 cases of invasive premenopausal breast
cancer were confirmed. Physical activity was assessed by self-report at baseline and during follow-up using a validated questionnaire.
Total physical activity was unrelated to risk of breast cancer. Women engaging in X27 metabolic equivalent (MET)-hweek
 1 had a
multivariate-adjusted relative risk (RR) of 1.04 (95% confidence interval (CI) 0.82–1.33) compared to those in the o3 MET-
hweek
 1 category. Among women with a BMI X30kgm
 2, we observed a significant positive dose–response relation (P¼0.04).
Activity was unrelated to breast cancer risk at lower levels of BMI. A test for interaction between activity and BMI (o30,
X30kgm
 2) was statistically significant (P¼0.02). Among current OC users, higher activity was associated with a non-significantly
lower risk of breast cancer (RR¼0.59, 95% CI 0.30–1.16 for X27 vs o9 MET-hweek
 1, P for linear trend¼0.14). These results
show no overall association between physical activity and risk of breast cancer among premenopausal women, but suggest that the
effect of physical activity could be substantially modified by the underlying degree of adiposity. The potential interactions between
physical activity, adiposity, and current use of OCs require further study.
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The relation of physical activity to risk of breast cancer has been
assessed by the International Agency for Research on Cancer,
which concluded that, although studies have not been entirely
consistent, the overall results support a reduction in risk with
higher levels of activity (International Agency for Research on
Cancer, 2002). The majority of studies, however, have been focused
on postmenopausal breast cancer. Also, upon review of more than
30 studies, it was noted that the most important time periods in life
for activity is not currently known. Furthermore, which activities
may offer the greatest protection have not been systematically
examined.
In a previous analysis of the Nurses’ Health Study II (NHSII)
cohort with 372 cases among predominantly premenopausal
women, Rockhill et al (1998) observed no association between
nonoccupational activity levels in late adolescence or the recent
past and risk of breast cancer. We now extend that analysis, adding
477 additional premenopausal cases in an effort to understand
better the relation between physical activity and risk of
premenopausal breast cancer.
In addition to evaluating the type of physical activity, we
examined the relation between activity and breast cancer within
subgroups of adiposity and oral contraceptive (OC) use, which we
hypothesised, might modify the relationship. Potential health
effects of (OCs) were the original focus of the NHS II cohort.
METHODS
The NHS II began in 1989 when 116671 female registered nurses
between 25 and 42 years of age and living within 14 US states
responded to an initial mailed questionnaire. Follow-up ques-
tionnaires are sent every 2 years and the response rate has been at
least 90% in each cycle. Participants report diagnosed diseases and
information on lifestyle and other risk factors for disease. Deaths
are detected by reports from the postal service or family members
and by a search of the National Death Index (Stampfer et al, 1984).
This analysis includes the 110468 premenopausal women who
responded to the physical activity questions at baseline and had
not reported a previous diagnosis of any cancer other than
nonmelanoma skin cancer.
Breast cancer cases
Over the 10 years of follow-up among the premenopausal women,
we obtained medical records from 977 (88%) of the 1106 reported Received 3 March 2003; revised 4 June 2003; accepted 6 June 2003
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ydiagnoses of breast cancer prior to 1 June, 1999 and before
menopause, defined as cessation of menses due to natural causes,
surgery, radiation, or chemotherapy. From the medical records,
761 (78%) were confirmed as invasive cancer and included as cases
in this analysis; the other 22% were in situ and were excluded.
Owing to the high degree of self-reporting accuracy, we included in
analysis the 88 reports that were confirmed verbally or in writing
by the participant but for which we could not obtain medical
records, bringing the final breast cancer case count to 849. The
median age at diagnosis was 42 years.
Activity assessment
In 1989, participants reported their average amount of time spent
per week during the previous year in each of eight activities:
walking or hiking outdoors, jogging (410minmile
 1), running,
bicycling (including stationary machine), racquet sports, lap
swimming, calisthenics/aerobics, and other aerobic activity.
Although most of these activities were recreational, walking could
be nonrecreational. For each activity, women chose one of 10
duration categories that ranged from zero to 11 or more hours per
week. Walking pace was also reported as easy, average, brisk, or
very brisk. Activity was reassessed in 1991 and 1997.
Each activity on the questionnaire was assigned a metabolic
equivalent (MET) score based on the classification by Ainsworth
et al (1993). The MET score for an activity is defined as the ratio of
the metabolic rate associated with that activity divided by the
resting metabolic rate. For example, walking at an average pace,
jogging, and running were assigned MET scores of 3, 7 and 12,
respectively. We calculated MET-hweek
 1 for each activity as the
reported hours per week engaged in the activity multiplied by the
assigned MET score, and the values from the individual activities
were summed for a total MET-hweek
 1. To obtain the best long-
term measure of activity, values for total MET-hweek
 1 were
cumulatively averaged in analyses; that is, at the beginning of each
2-year follow-up cycle, MET-hweek
 1 was the mean of all MET-
hweek
 1 calculated from the questionnaires up to that time. We
selected cutpoints for data analysis a priori to be in three MET
increments because three METs is the score for 1h of walking and
we wanted to be able to describe results from our MET-h analyses
in terms of the equivalent amount of walking.
The ability of the questionnaire to assess total activity over the
previous year was evaluated in a sample of 151 NHS II women
(Wolf et al, 1994). Compared with four 7-day activity diaries, the
questionnaire underascertained activity by approximately 20%.
However, the correlation for total MET-hweek
 1 of activity was
0.62 (95% confidence interval (CI) 0.44–0.75), indicating that the
questionnaire is a reasonable tool for categorical ranking. For
walking, the primary activity among the women in this cohort, the
correlation was 0.70 (95% CI 0.49–0.84) when the past-year
activity questionnaire was compared with four past-week ques-
tionnaires collected seasonally during the year.
Other risk factors
Weight, use of OCs, reproductive history, and diagnosis of benign
breast disease were reported at baseline in 1989 and updated on
each follow-up questionnaire. Age at menarche, height, and weight
at age 18 years were reported once in 1989. Alcohol consumption
was assessed in 1991 and 1995 from a food frequency ques-
tionnaire, and family history (mother or sister) of breast cancer
was reported in 1989 and again in 1997. Current body mass index
(BMI, kgm
 2) and BMI at age 18 years were calculated from the
reported weights and height (Rimm et al, 1990; Troy et al, 1995),
and weight change was calculated as the difference in weight at age
18 years and the current weight in each 2 years follow-up cycle.
Time since last birth was also calculated and updated in each
follow-up cycle.
Statistical analysis
Study participants contributed person-time from the return date
of their 1989 questionnaire until menopause, the report of a
diagnosis of breast cancer or other cancer (except nonmelanoma
skin cancer), death, or the end of follow-up on 1999 June 1. The
110468 women in this analysis contributed a total of 934082
person-years. Person-time was allocated to the appropriate
category for activity and for each of the risk factors at the
beginning of every 2-year follow-up cycle. Breast cancer incidence
rates were calculated as the number of cases divided by the person-
time in each activity category and relative risks (RR) were the
ratio of the rate in each upper category compared with the rate
in the lowest or referent category. The Cox proportional hazards
models were used to calculate multivariate RRs adjusted for all
risk factors (Cox, 1972). The P-values for linear trend were
determined using continuous activity values in the proportional
hazards models. The level of statistical significance in all analyses
was Po0.05.
RESULTS
At baseline in 1989, the median total activity among the
premenopausal women in the study population was 13 MET-
hweek
 1; 9% reported zero or minimal activity (i. e., no more than
15minweek
 1). Walking, the most popular activity, was reported
by 84% of the women and contributed 32% of the total MET-h.
Calisthenics/aerobics (19%), other aerobic activity (16%), and
biking (16%) were the other major contributors.
More active women had a lower BMI, consumed somewhat more
alcohol, and were more likely to be nulliparous than sedentary or
less-active women (Table 1). Other risk factors for breast cancer,
including age, height, age at menarche, OC use, parity, age at first
birth, history of benign breast disease, and family history of breast
cancer were unrelated to activity.
Total physical activity was unrelated to risk of breast cancer
(Table 2). In the multivariate-adjusted analyses, women engaging
in X27 MET-hweek
 1 had an RR of 1.04 (95% CI 0.82–1.33)
compared to those in the o3 MET-hweek
 1 category. Adjustment
for the risk factors, including BMI, only slightly attenuated the RRs
adjusted only for age. Results were also unchanged when we
included BMI at age 18 years and weight change since age 18 years,
instead of current BMI, in the multivariate model, or when we
included time since last birth instead of parity and age at first birth
(data not shown).
We also evaluated specific low-intensity (walking) and high-
intensity (running or jogging) activities (Table 3). Walking was
unrelated to breast cancer risk (RR¼1.07, 95% CI 0.81–1.40, for
X4hweek
 1 vs o20min/wk), while women who ran or jogged for
X2hweek
 1 had a nonsignificantly lower risk (RR¼0.71, 95% CI
0.45–1.12, P for linear trend¼0.10) compared to those who did
not engage in either activity. Running and jogging were reported
by only 6 and 10%, respectively, of the women in this study,
providing modest power for analysis.
We examined the relation between total physical activity and
risk of breast cancer within strata of several risk factors (Table 4).
Among women with a BMI X30kgm
2, we observed a significant
positive dose–response relation (P¼0.04), although the RR in the
highest activity category of X27 MET-hweek
 1 was not significant
(RR¼1.53, 95% CI 0.89–2.63). Activity was unrelated to breast
cancer risk at lower levels of BMI. A test for interaction between
activity (five categories) and BMI (o30, X30kgm
 2) was
statistically significant (P¼0.02). Among current OC users, higher
activity was associated with a lower risk of breast cancer
(RR¼0.59, 95% CI 0.30–1.16 for X27 vs o9 MET-hweek
 1, p
for linear trend¼0.14), although a test for interaction between
activity (five categories) and OC use (never/past, current) was not
statistically significant (P¼0.08). An inverse association was
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duration users, although power to assess these relations was low.
Also, there was no indication of an inverse association for physical
activity once OC use ended. Among the past users who stopped
taking OCs within the last 5 years, the relative risk was 1.20 (95%
CI 0.57–2.49) for X27 vs o3 MET-hweek
 1. In other stratified
analyses, associations between physical activity and risk of breast
cancer remained null when limited to women o40 or X40 years of
age or to nulliparous or parous women, and in strata of smoking
and alcohol intake (data not shown).
DISCUSSION
In these prospective data among premenopausal women, we
observed no overall association between recent physical activity
Table 1 Breast cancer risk factors according to categories of MET-h per week among the 110468
premenopausal women in the NHS II study population
a
MET-h/Week
 1 (median)
o3 (1.6) 3–8.9 (5.8) 9–17.9 (12.9) 18–26.9 (21.9) X27 (41.7)
Age (years) 38.4 38.5 38.4 38.1 37.5
BMI (kgm
 2) 26.3 25.7 25.1 24.7 24.1
Height (cm) 164 165 165 165 165
Alcohol intake (gday
 1) 2.5 2.8 3.1 3.4 3.7
Age at menarche o12 years (%) 25 25 24 24 24
Oral contraceptive user (%) 9 10 10 11 11
Nulliparous (%) 19 19 21 24 28
Parity
b 2.2 2.2 2.2 2.2 2.2
Age at first birth
b (years) 26 26 26 26 26
History of benign breast disease (%) 34 36 36 35 35
Mother or sister with breast cancer (%) 6 7 6 6 6
aValues are the mean or the percent of the person-time over follow-up from 1989 to 1999, standardized to the age
distribution of the study population.
bParity and age at first birth were calculated among parous women only.
Table 2 Relative risks (RR) of breast cancer (n¼849) by total activity among premenopausal women in the NHS II cohort, 1989–1999
NHS
Person-years
(thousands) Cases
Age-adjusted RR
(95% CI)
Multivariate
a
without BMI RR (95% CI)
Multivariate
b with
BMI RR (95% CI)
Total activity (MET-hweek
 1)
o3 106.1 95 1.00 1.00 1.00
3–8.9 217.5 210 1.07 (0.84–1.37) 1.05 (0.82–1.34) 1.05 (0.82–1.33)
9–17.9 225.5 197 0.99 (0.77–1.26) 0.96 (0.75–1.23) 0.95 (0.74–1.21)
18–26.9 140.2 131 1.08 (0.83–1.41) 1.05 (0.80–1.37) 1.03 (0.79–1.35)
X27 244.8 216 1.10 (0.86–1.40) 1.07 (0.84–1.36) 1.04 (0.82–1.33)
P for linear trend 0.57 0.69 0.86
aAdjusted for age, height, alcohol intake, age at menarche, age at first birth, oral contraceptive use, history of benign breast disease, and mother or sister with breast cancer.
bAdjusted for the factors listed above plus BMI.
Table 3 Relative risks (RR) of breast cancer by time spent walking and by time spent running or jogging
among premenopausal women in the NHS II cohort, 1989–1999
Person-years
(thousands) Cases
Age-adjusted RR
(95% CI)
Multivariate
a RR
(95% CI)
Walking
o20minweek
 1 166.2 126 1.00 1.00
20–59minweek
 1 239.3 228 1.16 (0.93–1.44) 1.17 (0.94–1.46)
1–1.9hweek
 1 251.9 241 1.20 (0.97–1.49) 1.20 (0.97–1.50)
2–3.9hweek
 1 157.7 160 1.27 (1.00–1.60) 1.23 (0.97–1.57)
X4hweek
 1 119.0 94 1.07 (0.82–1.40) 1.07 (0.81–1.40)
P for linear trend 0.74 0.80
Running or jogging
None 760.4 701 1.00 1.00
o1hweek
 1 107.9 92 0.94 (0.76–1.17) 0.92 (0.74–1.15)
1–1.9hweek
 1 36.5 37 1.20 (0.48–1.19) 1.15 (0.83–1.61)
X2hweek
 1 29.3 19 0.76 (0.48–1.19) 0.71 (0.45–1.12)
P for linear trend 0.20 0.10
aAdjusted for age, BMI, height, alcohol intake, age at menarche, age at first birth, oral contraceptive use, history of benign
breast disease, mother or sister with breast cancer, and MET-hweek
 1 from other activities.
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specific activities we observed a nonsignificant reduction in risk of
some 30% among women who run or jog for 2 or more hours per
week, but no reduction in risk among women who walk regularly.
Within strata of risk factors, we observed no protection among
lean women and a significant trend of increased risk with higher
activity levels among obese premenopausal women. We also
observed a suggestion of reduced risk among current users of OCs
that was independent of duration of use.
These data on physical activity have been assessed using an
instrument that was validated in the current population and shown
to classify women reasonably well. Using the same activity
assessment in parallel studies among slightly older women we
have shown that greater activity predicts reduced risk of diabetes
(Hu et al, 1999), heart disease (Manson et al, 1999), stroke (Hu
et al, 2000), colon cancer (Martinez et al, 1999), osteoporotic
fractures (Feskanich et al, 2002), and reduced weight gain after
smoking cessation (Kawachi et al, 1996). In the NHS II, higher
physical activity predicts reduced ovulatory infertility (Rich-
Edwards et al, 2002), and is strongly related to lower BMI. Other
lifestyle exposures considered as confounders and effect
modifiers in this prospective study have also shown high
levels of validity in self-report (Troy et al, 1995; Hunter et al,
1997). High follow-up and confirmation rates of cancer among
these cohort participants further reduces the potential for bias in
these results.
The finding for type of activity and reduction in breast cancer
risk may offer some insight into the potential source of variation in
the findings among the studies to date. In this cohort, although the
results for strenuous activities of running and jogging were of
borderline significance for 2 or more hours per week, power was
limited because only 3% of women reported running and jogging
at this level.
As the prevalence of obesity continues to rise in the US (Flegal
et al, 2002), the observation that among premenopausal women
higher activity among obese women is directly related to risk may
offer an explanation for the lack of an overall reduction in risk
within this population. Previous studies observing a strong inverse
association among premenopausal women have, on average, been
conducted among women with lower BMI. Verloop et al (2000),
using a case–control design, evaluated 998 cases among women
younger than 55 years of age in the Netherlands, with a mean BMI
of 24.2kgm
 2. They observed a stronger protection for lifetime
recreational activity among lean women (RR¼0.57; 95% CI 0.40–
0.82) and no reduction in risk among women with BMI greater
than 24.5kgm
 2. (RR¼0.92; 95% CI 0.65–1.29). Bernstein et al,
using a case-control design, evaluated 545 cases diagnosed among
women less than age 40 years and observed greatest protection
among women with sustained activity from adolescence through
early adult years. In that population 75% of women had a BMI
below 25kgm
 2, substantially leaner than the average US
population in the late 1980’s when 25.8% of women 30 to 39 years
of age were obese (430kgm
 2) (Flegal et al, 2002). Coogan et al
(1997) also reported a stronger association among leaner women,
but like several other case–control studies, the test for interaction
was not significant. Among postmenopausal women, several
studies have noted that the inverse association with higher activity
is only evident among women who have not gained substantial
weight during their adult years (Carpenter et al, 1999; Shoff et al,
2000). Several other case–control studies limited to, or predomi-
nantly including, premenopausal breast cancer have often failed to
show an inverse association with level of recent or sustained
physical activity and report no variation in the association by level
of BMI (Chen et al, 1997; Gammon et al, 1998; Friedenreich et al,
2001). In the only prospective study stratifying results according to
BMI, Thune et al (1997) followed women in Norway and observed
a significant inverse trend in risk among lean women (P trend
¼0.02 among women less than 22.8kgm
 2), but not among
average weight or overweight women (P trend¼0.90 and 0.36
respectively).
Physical activity may reduce risk of breast cancer through
several possible mechanisms including change in hormonal
exposure, change in immune function, and (in postmenopausal
women) reduction in weight gain. To date, immune function has
not been related to risk of breast cancer and hence this potential
mechanism is not discussed further. Very high levels of activity
may reduce the frequency of ovulation or the length of the luteal
phase (Bernstein et al, 1987), thus reducing exposure to oestradiol
Table 4 Relative risks (RR) of breast cancer by total activity, stratified by BMI and by oral contraceptive (OC) use, among premenopausal women in the
NHS II cohort, 1989–1999
BMI o25kgm
 2 BMI 25–29.9kgm
 2 BMI X30kgm
 2
Person years
(thousands) Cases
Multivariate
a
RR (95% CI)
Person-years
(thousands) Cases
Multivariate
a
RR (95% CI)
Person-years
(thousands) Cases
Multivariate
a
RR (95% CI)
Total Activity (MET-h/week
 1)
o3 56.7 52 1.00 24.1 20 1.00 24.4 22 1.00
3–8.9 123.1 120 1.06 (0.7601.47) 50.8 49 1.12 (0.66–1.88) 42.4 40 0.95 (0.56–1.60)
9–7.9 137.6 120 0.95 (0.69–1.32) 51.4 50 1.14 (0.67–1.92) 35.4 27 0.76 (0.43–1.34)
18–26.9 90.0 88 1.03 (0.77–1.52) 31.0 33 1.28 (0.73–2.23) 18.5 10 0.56 (0.26–1.18)
X27 170.6 144 1.04 (0.72–1.36) 47.9 36 0.98 (0.57–1.70) 24.9 35 1.53 (0.89–2.63)
P for linear
trend
0.89 0.57 0.04
OC use¼never OC use¼past OC use¼current
Total Activity (MET-h/week
 1)
o3 16.0 11 1.00 78.1 79 1.00
3–8.9 32.5 28 1.23 (0.63–2.56) 160.8 158 0.94 (0.72–1.23) 28.9 25 1.00
b
9–17.9 33.1 33 1.48 (0.74–2.95) 165.7 140 0.81 (0.61–1.07) 22.6 21 1.07 (0.59–1.92)
18–26.9 20.5 20 1.50 (0.71–3.16) 102.1 100 0.95 (0.71–1.28) 15.2 10 0.75 (0.35–1.57)
X27 36.1 26 1.19 (0.58–2.42) 173.4 175 1.04 (0.79–1.36) 29.5 14 0.59 (0.30–1.16)
P for linear
trend
0.80 0.46 0.14
aAll RRs were adjusted for age, BMI, height, alcohol intake, age at menarche, parity, age at first birth, history of benign breast disease, and mother or sister with breast cancer.
Analyses stratified by BMI were additionally adjusted for OC use.
bReference category is o9 MET-hweek
 1 due to small numbers (four cases and 9038 person-years) in the o3
MET-hweek
 1 category.
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insufficient to cause anovulation may also reduce oestrogen levels
(Bullen et al, 1985). Among premenopausal women, increasing
BMI is associated with lower risk of breast cancer (van den Brandt
et al, 2000), and this has been hypothesised to result from
anovulation induced by insulin resistance, which is reduced by
physical activity. The increase in risk associated with greater
physical activity among obese premenopausal women could then
be due to a reduction in insulin resistance and increased frequency
of ovulation. Indirect evidence supporting this hypothesis comes
from the current prospective cohort study in which we have
observed that obese women have more irregular menstrual cycles,
and greater risk of infertility (Rich-Edwards et al, 1994), and that
regular activity is associated with reduced anovulatory infertility
(Rich-Edwards et al, 2002). Furthermore, in this cohort, irregular
menstrual cycles and anovulatory infertility are associated with
reduced risk of premenopausal breast cancer (Garland et al, 1998).
The suggestion of a benefit among women who currently use OCs
would be compatible with a lack of adverse effect by reducing
ovulation (users are all anovulatory) combined with a benefit
independent of ovulation.
In conclusion, these data among premenopausal women suggest
that there is no overall association between activity and risk of
breast cancer. However, benefits from high-intensity activity such
as running and jogging cannot be excluded and require further
evaluation. Our findings also suggest that the effect of physical
activity could be substantially modified by the underlying degree
of adiposity. The potential interactions between physical activity,
adiposity, and current use of oral contraceptives require additional
study.
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